 | Up a level |
Tosco, Lorenzo; Laenen, Annouschka; Briganti, Alberto; Gontero, Paolo; Karnes, R Jeffrey; Bastian, Patrick J; Chlosta, Piotr; Claessens, Frank; Chun, Felix K; Everaerts, Wouter; Gratzke, Christian; Albersen, Maarten; Graefen, Markus; Kneitz, Burkhard; Marchioro, Giansilvio; Salas, Rafael Sanchez; Tombal, Bertrand; Van den Broeck, Thomas; Van Der Poel, Henk; Walz, Jochen; ... (2018). The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis. European urology focus, 4(3), pp. 369-375. Elsevier 10.1016/j.euf.2016.12.008
Litovkin, Kirill; Van Eynde, Aleyde; Joniau, Steven; Lerut, Evelyne; Laenen, Annouschka; Gevaert, Thomas; Gevaert, Olivier; Spahn, Martin; Kneitz, Burkhard; Gramme, Pierre; Helleputte, Thibault; Isebaert, Sofie; Haustermans, Karin; Bollen, Mathieu (2015). DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer. PLoS ONE, 10(6), e0130651. Public Library of Science 10.1371/journal.pone.0130651
Litovkin, Kirill; Joniau, Steven; Lerut, Evelyne; Laenen, Annouschka; Gevaert, Olivier; Spahn, Martin; Kneitz, Burkhard; Isebaert, Sofie; Haustermans, Karin; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu (2014). Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer. Journal of cancer research and clinical oncology, 140(11), pp. 1849-1861. Springer 10.1007/s00432-014-1738-8
